IFNG and in situ carcinoma: An additional role for the constitutively elevated CIS may be to decrease breast cancer sensitivity to interferons, similar to the decreased sensitivity to IFNγ seen in cutaneous T-lymphoma (CTCL) cell lines that constitutively express SOCS-3 (Brender et al, 2001).